NEWS


Here are some of our most recent news announcements.

Johnson Matthey rebrands its Fine Chemicals Division

West Deptford, N.J. – 15th September 2015 – Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has today unveiled the distinctive new branding for its Fine Chemicals Division.

read more

Johnson Matthey Acquires Pharmaceutical Manufacturing Capacity in Scotland, UK

West Deptford, N.J. – Dec. 2, 2014 – Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The 109,000 sq. metre site was acquired to meet increasing demand for custom pharmaceutical services and active ingredients utilising enhanced manufacturing capabilities.

read more

For more information on these developments, please contact FineChemicals@matthey.com

For information on Johnson Matthey or our sister divisions, please visit matthey.com